Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 4
2021 2
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift.
Hieken TJ, Kreidieh F, Aedo-Lopez V, Block MS, McArthur GA, Amaria RN. Hieken TJ, et al. Among authors: aedo lopez v. Am Soc Clin Oncol Educ Book. 2023 Jan;43:e390614. doi: 10.1200/EDBK_390614. Am Soc Clin Oncol Educ Book. 2023. PMID: 37116111 Free article.
[Advances in Oncology 2019].
Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S, Stravodimou A, Sarivalasis A. Vernadou A, et al. Among authors: aedo lopez v. Rev Med Suisse. 2020 Jan 15;16(676-7):72-77. Rev Med Suisse. 2020. PMID: 31961089 Review. French.
Adult Wilms tumour: A case report.
Mounnarath ET, Zwieky W, Aedo-Lopez V, Fazli O, Sheridan BJ. Mounnarath ET, et al. Among authors: aedo lopez v. SAGE Open Med Case Rep. 2022 May 11;10:2050313X221097265. doi: 10.1177/2050313X221097265. eCollection 2022. SAGE Open Med Case Rep. 2022. PMID: 35573098 Free PMC article.
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors.
da Silva Lopes AM, Colomer-Lahiguera S, Darnac C, Giacomini S, Bugeia S, Gutknecht G, Spurrier-Bernard G, Aedo-Lopez V, Mederos N, Latifyan S, Addedo A, Michielin O, Eicher M. da Silva Lopes AM, et al. Among authors: aedo lopez v. Support Care Cancer. 2023 Jul 22;31(8):484. doi: 10.1007/s00520-023-07934-w. Support Care Cancer. 2023. PMID: 37480546 Free PMC article. Clinical Trial.
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study.
Da Silva Lopes AM, Colomer-Lahiguera S, Mederos Alfonso N, Aedo-Lopez V, Spurrier-Bernard G, Tolstrup LK, Pappot H, Aspeslagh S, Rogiers A, Neyns B, Haanen JB, Mitchell SA, Addeo A, Michielin O, Eicher M. Da Silva Lopes AM, et al. Among authors: aedo lopez v. Eur J Cancer. 2021 Nov;157:225-237. doi: 10.1016/j.ejca.2021.08.026. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536946 Free article.
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
Ressler JM, Karasek M, Koch L, Silmbrod R, Mangana J, Latifyan S, Aedo-Lopez V, Kehrer H, Weihsengruber F, Koelblinger P, Posch C, Kofler J, Michielin O, Richtig E, Hafner C, Hoeller C. Ressler JM, et al. Among authors: aedo lopez v. J Immunother Cancer. 2021 Feb;9(2):e001701. doi: 10.1136/jitc-2020-001701. J Immunother Cancer. 2021. PMID: 33608376 Free PMC article.
16 results